UH Cleveland Medical Center (0 mi.)
11100 Euclid Ave
Cleveland, OH 44106
UH Minoff Health Center at Chagrin Highlands (7 mi.)
3909 Orange Pl
Beachwood, OH 44122
UH Seidman Cancer Center (18 mi.)
29325 Health Campus Dr
Westlake, OH 44145
Biography: Lee Ocuin, MD
- Associate Professor of Surgery, CWRU School of Medicine
Certifications & Memberships
- Complex General Surgical Oncology - American Board of Surgery
- Surgery - American Board of Surgery
Fellowship | Robotic Hepatopancreatobiliary Surgery
Robotic Hepatopancreatobiliary Surgery - Atrium Health Carolinas Medical Center (2017 - 2017)
Fellowship | Hepato-Pancreato-Biliary Surgery
Hepato-Pancreato-Biliary Surgery - Mayo Clinic (2016 - 2017)
Fellowship | Surgical Oncology
Surgical Oncology - University Of Pittsburgh Medical Center UPMC (2014 - 2016)
Research Fellowship | Hepato-Pancreato-Biliary Surgery
Hepato-Pancreato-Biliary Surgery - Memorial Sloan-Kettering Cancer Center (2008 - 2011)
Residency | General Surgery
General Surgery - Emory University Hospital (2006 - 2014)
Tufts University School Of Medicine (2006)
Brandeis University (2002)
Lee M. Ocuin, MD, joined University Hospitals as a faculty surgeon in the Division of Surgical Oncology in April 2021. Specializing in hepatopancreatobiliary surgery, Dr. Ocuin is also an Associate Professor of Surgery at Case Western Reserve University School of Medicine. He graduated cum laude from Brandeis University (Waltham, Massachusetts) in 2002, where he earned a Bachelor of Science in Biochemistry and Biology. He obtained his medical degree from Tufts University School of Medicine (Boston, Massachusetts) in 2006 and was elected to the Alpha Omega Alpha Honor Medical Society.
Dr. Ocuin completed his general surgery residency at Emory University School of Medicine (Atlanta, Georgia) in 2014. During his time as a resident, he completed a postdoctoral research fellowship in the Department of Surgery, Hepatopancreatobiliary Section, at Memorial Sloan Kettering Cancer Center (New York, New York). Between 2014 and 2017, Dr. Ocuin also completed a fellowship in complex general surgical oncology at the University of Pittsburgh Medical Center (Pittsburgh, Pennsylvania) and a fellowship in hepatopancreatobiliary surgery at Mayo Clinic (Rochester, Minnesota). His clinical and research expertise are focused on malignancies of the pancreas, liver and biliary tract. Dr. Ocuin is the principle investigator, co-PI, or site-based PI on five pending prospective clinical trials focusing on pancreatic cancer, pancreas surgery, cholangiocarcinoma and colorectal liver metastases.
Prior to joining UH and Case Western Reserve University School of Medicine, Dr. Ocuin was the Site-Based Medical Director of the Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery at Atrium Health - Cabarrus. He is currently the co-leader of the GI disease team at Seidman Cancer Center and the Surgical Director of the institution's Hepatic Artery Infusion Pump Program.
Dr. Ocuin is a member of various professional societies, among them the Americas Hepato-Pancreato-Biliary Association, American College of Surgeons, Society for Surgery of the Alimentary Tract, Society of Surgical Oncology and American Society of Clinical Oncology. In addition, he serves on the editorial boards and is a peer reviewer for multiple high-impact journals.
Patient Experience Reviews
Very pleased with all services at UH
Would highly recommend Dr. Ocuin. Seemed to know his profession very well.
Compassionate Excellent doctor
Dr Lee Ocuin the best oncologist surgeon I ever had and his team of residents doctors and medical students
They atayed on top of things and scheduled my procedure immediately...just like they said they would...Thank you
Dr Ocuin is a gift and helps in very difficult times He has set a standard of care that is admirable and greatly appreciated.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Lee Ocuin did not disclose any Outside Relationships with Industry.